Advanced Oncotherapy Share Discussion Threads

[tevita] 31/7/2017 08:16

hello ANDY PANDY
being nosey again

[andy] 31/7/2017 08:10

waterloo,

Yes and they have to finance themselves through to then!

I wonder how?

[mrtruth1] 31/7/2017 08:04

Fine, long term hold fully on target.

[waterloo01] 31/7/2017 07:37

Not even ready for full testing till end 2018!

[daijavu] 30/7/2017 20:06

I wish you luck.

[mrtruth1] 30/7/2017 19:28

Absolutely fair point. I just wanted in on the low price.

[daijavu] 30/7/2017 18:25

I agree that LIGHT seems to have great potential.

I am merely pointing out the great risk that AVO might not be part of the picture no matter how successful LIGHT proves to be.

It is that risk that prevents me investing in AVO.

[mrtruth1] 30/7/2017 17:21

The potential is hugely important to realise here.

[daijavu] 30/7/2017 14:06

mrtruth.

The potential size of the market is not an issue.

The issue is whether AVO will still exist when/if LIGHT is fully developed and in production.

I might happily buy back in if AVO still exists when LIGHT is complete. Until then I see the share price dropping and the high possibility that there could be a takeover once the hard work is done.

[mrtruth1] 26/7/2017 12:23

Came across this today. Reads well. Big potential (to say the least).

[johnjohntaylor] 26/7/2017 11:57

Is this likely to stay around the 15-16 mark until the next big news comes? Want to time buying in well again (if possible). What could this potentially reach on positive technology updates?

[mrtruth1] 24/7/2017 16:49

Pretty big buy at 1:08pm. Whoever that is must have some faith!

[andy] 23/7/2017 11:57

daijavu,

I would imagine the decision to go with the development machine is down to cost, if you leave it in Geneva, you have to fund the first production machine as well, increasing capex.

[andy] 23/7/2017 11:56

vatna,

Put me down for 14p.


Will,

Yes that is the fear here, shareholders fund the development and then it gets taken just before commerciality.

I don't think they'll get so close here, those large investors would surely prefer to take it private?

[wi1l] 23/7/2017 10:25

Agree with JacKnife. Saw similar 10 years ago with HML and lost a fortune when the co was put into liquidation.The directors a couple of months previous to this organised a loan to the co with a charge on all the assets and just helped themselves when the co became insolvent and was put into liquidation. Shareholders lost everything.

[daijavu] 23/7/2017 10:10

People might like to reflect on what AVO originally promised us and why it is unwise to invest in AVO until it is very clear that they have met all targets.

I have a copy of the original development schedule issued by AVO at their presentation on the 21st November 2014:

I tried to copy and paste it on here for everyone to see but the ADVFN website won't accept it.

The schedule states that integration and testing of LIGHT would take place during the period August to December 2016 with the facility in Harley Street ready by the end of Q2 2017 and the first patient treated before the end of 2017

AVO were still insisting in January/ February 2017 that the development of LIGHT was on track before they finally admitted that it was far from the case. That delay in owning up to the truth, despite being asked for the facts many times by investors growing concerned by obvious delays, led to loss of investor confidence, contributed to the drop in the share price and cost many loyal, long term, investors a lot of money.

I suggest that current investors bear that track record in mind before accepting AVO's current statements uncritically.

I would also seek clarification about what LIGHT machine is going into Harley Street.

It was originally going to be the development model but that changed to being the first production model coming out of Thales with the development model being retained in Geneva as a test bed for further research and development.

It now seems that AVO has changed their minds and it is the original development machine that will go into Harley Street after all. Thales will not commence commercial production until after the development machine has been installed at Harley Street.

The analysis paper produced by Hardman&Co on the 15th March 2017 states that to be the case but without referring to the original plan or explaining what has changed that caused the U turn. AVO is also being coy about it.

If I were still an AVO investor I would be tempted to ask AVO why they have changed their minds. Why isn't the first production model out of Thales going into Harley Street when they told us that it would? What are the problems with the Thales agreement that have caused the U turn?

[mrtruth1] 22/7/2017 22:52

I'd imagine it staying stable around 16-18 (Hopefully). GLA

[johnjohntaylor] 22/7/2017 22:46

No thoughts on the question of next week? Guess it depends on news updates. I'm new to AVO. Looks superb.

[vatnabrekk] 22/7/2017 22:20

More importantly - what will be the share price at the end of September? It's about then that they will run out of funds again. And that's when we'll find out if a Financial Institution is prepared to back them. And if not, well I'll leave it there for now.

[johnjohntaylor] 22/7/2017 21:57

SP next Friday...

Seems to be a lot of egos on here. How about a best guess at the share price next Friday? Straight answer. I'll say 21.

[mrtruth1] 21/7/2017 22:18

I'm not delusional, thanks though.

[mrtruth1] 21/7/2017 19:18

I think, actually, they would rather like to see it succeed and bring in a huge amount of money and groundbreaking treatment for sufferers. Long term hold.

[mrtruth1] 21/7/2017 17:49

I'm 100% not an insider.